BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28797453)

  • 1. Oncogenic signalling pathways in benign odontogenic cysts and tumours.
    Diniz MG; Gomes CC; de Sousa SF; Xavier GM; Gomez RS
    Oral Oncol; 2017 Sep; 72():165-173. PubMed ID: 28797453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular basis of odontogenic cysts and tumours.
    Gomes IP; Bastos VC; Guimarães LM; Gomes CC
    J Oral Pathol Med; 2023 Apr; 52(4):351-356. PubMed ID: 36629457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 and MDM2 expression in odontogenic cysts and tumours.
    Carvalhais J; Aguiar M; Araújo V; Araújo N; Gomez R
    Oral Dis; 1999 Jul; 5(3):218-22. PubMed ID: 10483067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing pathogenic mutations in dental follicles as an attempt to identify early events in odontogenic tumours tumourigenesis.
    Coura BP; de Resende TAC; de Menezes VCB; Bernardes VF; de Sousa SF; Diniz MG; Gomez RS; Gomes CC
    Arch Oral Biol; 2020 May; 113():104523. PubMed ID: 31543246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is podoplanin expression associated with transforming growth factor-β signaling in odontogenic cysts and tumors?
    Etemad-Moghadam S; Alaeddini M
    J Oral Pathol Med; 2018 May; 47(5):519-525. PubMed ID: 29577431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of amelogenins in odontogenic epithelial tumours and cysts.
    Mori M; Yamada K; Kasai T; Yamada T; Shimokawa H; Sasaki S
    Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):319-25. PubMed ID: 2024453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of beta catenin across the domain of odontogenic lesions: A systematic review.
    Chatterjee S; Devi A; Kamboj M; Narwal A
    J Oral Pathol Med; 2023 Nov; 52(10):904-910. PubMed ID: 37840228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing of oncogenes and tumor suppressor genes in odontogenic myxomas.
    Santos JN; Sousa Neto ES; França JA; Diniz MG; Moreira RG; Castro WH; Gomez RS; de Sousa SF; Gomes CC
    J Oral Pathol Med; 2017 Nov; 46(10):1036-1039. PubMed ID: 28597929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of BRAFV600E mutation in odontogenic keratocysts.
    França JA; de Sousa SF; Diniz MG; Pereira TDSF; de Resende TAC; Santos JND; Gomez RS; Gomes CC
    J Oral Pathol Med; 2018 Feb; 47(2):186-191. PubMed ID: 29272070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of P63 expression in odontogenic lesions.
    Atarbashi Moghadam S; Atarbashi Moghadam F; Mokhtari S; Eini E
    Biomed Res Int; 2013; 2013():624176. PubMed ID: 24350278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of molecular and genetic alterations in selected benign odontogenic disorders.
    Cabay RJ
    Arch Pathol Lab Med; 2014 Jun; 138(6):754-8. PubMed ID: 24878015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological pathways involved in the aggressive behavior of the keratocystic odontogenic tumor and possible implications for molecular oriented treatment - an overview.
    Mendes RA; Carvalho JF; van der Waal I
    Oral Oncol; 2010 Jan; 46(1):19-24. PubMed ID: 20004133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on keratocystic odontogenic tumors].
    Li TJ; Sun LS; Luo HY; Yuan JW; Gao L; Gu XM; Li XF; Xu LL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Feb; 41(1):16-20. PubMed ID: 19221557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of EGFR investigation in odontogenic keratocyst: a narrative review.
    Vasiljevic V; Obradovic J; Jurisic V
    Mol Biol Rep; 2023 Aug; 50(8):7089-7098. PubMed ID: 37314601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation frequencies of cell-cycle associated genes in epithelial odontogenic tumours.
    Moreira PR; Guimarães MM; Gomes CC; Diniz MG; Brito JA; de Castro WH; Gomez RS
    Arch Oral Biol; 2009 Oct; 54(10):893-7. PubMed ID: 19679296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunolocalization of PTCH protein in odontogenic cysts and tumors.
    Barreto DC; Bale AE; De Marco L; Gomez RS
    J Dent Res; 2002 Nov; 81(11):757-60. PubMed ID: 12407090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunolocalization of podoplanin in benign odontogenic tumours with and without ectomesenchyme.
    Caetano Ados S; Tjioe KC; Faustino SE; Hanemann JA; Belone Ade F; Soares CT; Oliveira DT
    Arch Oral Biol; 2013 Apr; 58(4):408-15. PubMed ID: 22763018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular alterations in odontogenic keratocysts as potential therapeutic targets.
    Gomes CC; Guimarães LM; Diniz MG; Gomez RS
    J Oral Pathol Med; 2017 Nov; 46(10):877-882. PubMed ID: 28489259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Odontogenic tumors and neoplastic-like changes of the jaw bone. Clinical study and evaluation of treatment results].
    Stypułkowska J
    Folia Med Cracov; 1998; 39(1-2):35-141. PubMed ID: 10481376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Craniopharyngiomas and odontogenic tumors mimic normal odontogenesis and share genetic mutations, histopathologic features, and molecular pathways activation.
    Gomes CC; de Sousa SF; Gomez RS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Mar; 127(3):231-236. PubMed ID: 30598409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.